Table 1. ACA reduced eosinophil numbers in bronchoalveolar lavage fluid recovered from mice with OVA-induced asthma.

	NEUs	LYMs	EOSs	BASs	LUCs
	(×106)	(×106)	(×106)	(×106)	(×106)
Vehicle control	0.03±0.009	0.03±0.011	0.01±0.012	0.01±0.004	0.05±0.040
Albumin-induced asthma model	0.04±0.012	0.11±0.052 a	1.14±0.270 a	0.01±0.004	0.10±0.023
Dexamethasone treatment	0.02±0.005	0.03±0.010 b	0.27±0.150 b	0.01±0.002	0.08±0.034
25 mg/kg/day ACA treatment	0.07±0.077	0.08±0.049	0.73±0.299 a,b,c	0.01±0.023	0.13±0.059 a
50 mg/kg/day ACA treatment	0.02±0.007	0.04±0.019 b	0.34±0.198 b,d	0.01±0.004	0.07±0.019

Results are expressed as mean ± SD (n = 7). NEU, neutrophils; LYMs, lymphocytes; EOSs, eosinophils; BASs, basophils; LUCs, large unstained cells.

^a p<0.01 vs. CON (vehicle control); ^b p<0.01 vs. OVA (OVA-induced asthma model); ^c p<0.01 vs. DEX (dexamethasone treatment); ^d p<0.01 vs. ACA-25 mg (25 mg/kg/day ACA treatment).